We are live on ! Find out more
ARTLW

Artelo Biosciences, Inc. Warrant
ARTLW

Delisted

ARTLW was delisted on the 17th of June, 2024.

Back to rankings

5 hedge funds and large institutions have $2.76K invested in Artelo Biosciences, Inc. Warrant in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 4 → 5 (+1)

14% more capital invested

Capital invested by funds: $2.43K → $2.76K (+$334)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$6

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$469
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
1
Verition Fund Management
Connecticut
$1.78K – – –
AGM
2
Alpine Global Management
New York
$918 – – –
UBS Group
3
UBS Group
Switzerland
$48 -$469 -7,536 -92%
Morgan Stanley
4
Morgan Stanley
New York
$11 – – –
Bank of America
5
Bank of America
North Carolina
$7 +$6 +102 New

ARTLW Hedge Fund Activity: Q1 2023 in Review

5 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q1 2023, worth a combined $2.76K — up 14% from $2.43K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ARTLW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Bank of America, opening a new position worth an estimated $6. The largest seller was UBS Group, cutting an estimated $469.

  • 5 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q1 2023, up from 4 in Q4 2022.
  • Funds reported $2.76K of Artelo Biosciences, Inc. Warrant stock for Q1 2023, up 14% quarter-over-quarter.
  • 1 fund opened new Artelo Biosciences, Inc. Warrant positions in Q1 2023 and 0 closed out, a net change of +1 holder.
  • The largest Artelo Biosciences, Inc. Warrant buyer in Q1 2023 was Bank of America, an estimated $6 added.
  • The largest Artelo Biosciences, Inc. Warrant seller in Q1 2023 was UBS Group, an estimated $469 sold.

Based on aggregated 13F filings for Q1 2023.